Home Shop Online Sign Up / Log In First time here? Sign Up! All fields are required. Great Cbd Oil Can Cbd Oil Help With Nerves And Appetite 750mg …
CBD Cannabis Oil Medical Recreational Health
Josie Maran Cosmetics – owned by American model and entrepreneur Josie Maran – has launched a new vegan CBD and hemp elixir range.
Named Skin Dope, the new range includes an argan oil with 100 milligrams of CBD and a Hemp Seed Oil.
The cannabinoid – which can be derived from hemp or the cannabis plant – was recently legalized across the United States. Unlike THC, CBD has no psychoactive effects, and – according to some medical experts – its health benefits include soothing chronic pain, anxiety, depression, and assisting with sleep.
CBD also boasts anti-inflammatory benefits, which has caught the attention of a growing number of beauty brands. Maran’s Skin Dope aims to “leverage the power of cannabis,” according to its website, combining it with the “virtues of Argan oil,” one of Josie Maran’s staple ingredients. Both oils can be applied all over the face, either before or after serum or moisturizer. The Hemp Seed Oil works better underneath makeup and the CBD Oil is an effective nighttime treatment, says the brand.
“We’re cultivating a better state of being and a better state of mind,” says Skin Dope. It adds, “[Our] pure, organic ingredients are gently processed to maintain the full integrity of their nutrients. Safe, clean, and free from harmful contaminants, what it means for you is more nourishment, more relief — and more results.”
The Rise of the CBD Market
It’s not only the beauty industry that’s seeing CBD-infused products appear on the market. In the food and drink industry, CBD is also soaring in popularity.
Wellness snack company Weller recently launched CBD-infused Coconut Bites and Beverly Hills-based beverage brand Living Foods introduced CBD sparkling water. In the UK, Yogland added a new frozen yogurt made with the cannabinoid to its menu and vegan restaurant chain by CHLOE. launched its CBD snack range Feelz in its London locations.
According to Bloomberg, Vegan and CBD-infused wine are among the top trends set to transform the alcohol industry in 2019.
The publication reported, “With the legalization of pot in California, Canada, and elsewhere last year, wine and weed mixes are coming. Canadian investment bank Canaccord Genuity LLC suggested to Business Insider that marijuana-infused beverages could become a $600 million market in the U.S. in the next four years.”
The Hemp Seed Oil from Josie Maran’s Skin Dope range is available online from Josie Maran Cosmetics and in-store at Sephora. The CBD Oil is available online at Skin Dope.
Become a CLUBKINDLY member today!
Editor’s note: Making it in Vermont is an ongoing series by VTDigger’s business reporter Anne Wallace Allen looking at companies and industries driving innovation in the state. If you have ideas about inspiring entrepreneurs or companies, send them to Anne at [email protected]
Carl Christianson and Noah Quist have a 10,000-square-foot hemp processing building, the equipment they need to extract CBD, and about 600 pounds of hemp per week delivered by Vermont farmers.
“The point is room to grow,” said Christianson, who obtained a mortgage from Brattleboro Savings and Loan to buy the former bread factory in Brattleboro. “We wanted to build something for the future and make sure we were good for expansion.”
Expectations for Vermont’s hemp and CBD business were giddy even before passage of the farm bill. New processing facilities, hemp growers, products and stores have sprung up quickly in Vermont in the last few years since individual states started legalizing marijuana and the hemp derivative CBD. Vermont legalized recreational use of marijuana last year, and is widely expected to take up the matter of commercial sales in the legislative session underway now. In anticipation, the number of hemp growers who registered with Vermont as required grew more than 400 percent from 2017 to 2018.
A Hardwick hemp company last year reported it received $7 million from investors.
Scott Waring, a biologist who works as a consultant to hemp and CBD businesses, estimated there are eight to 12 large-scale hemp processing operations in Vermont. Northeast Processing is one of the larger operations, he said.
“It’s kind of a grand experiment going on right now,” he said. “The cream will rise to the top. It’s a matter of getting that regulation in there.”
Christianson and Quist received the loans and investment they needed from friends, family and others to buy the equipment for their large-scale processing operation in Vermont’s southeastern corner. They moved into their building in June and by the time the sale on the building closed in August, farmers had started getting in touch, said Quist.
“When we began to announce the fact that we’d be opening a high-volume extraction facility in Vermont, a lot of the farmers found us,” said Quist, who also used the state’s registry and Facebook to advertise to other growers. They are now confident they will get the hemp they need to reach their production goals. Christianson said the facility now uses 500 pounds to 750 pounds of hemp per week. Christianson expects the plant will be able to process 2,000 pounds per week in February if he has the staff and equipment in place.
“When we first started, it was, ‘Man, I hope we can find biomass,’” Quist said. “And then all of a sudden, especially around the harvest, we had thousands of pounds available to us.”
While Vermont hemp is harvested in the fall, the supply is year-round, Quist said.
“A lot of the farmers still have it hung up in their barns,” he said. “In the cold it preserves well, provided they hung it in time. They know there is value in what they have and they’re just looking for an outlet. As we continue to scale up I plan on being able to call them and saying ‘we’re ready for yours.’”
Quist said the plant is producing 65 kilograms of whole plant extract oil per month from the hemp.
A lot has happened with hemp and CBD in the short time since Quist and Christianson started their business. The passage of the farm bill legalized the growing and processing of hemp under federal law and prompted the Food and Drug Administration to declare in December that it would have oversight over hemp and CBD products.
Meanwhile, a company called Southern Vermont Wellness opened Vermont’s first CBD dispensary drive-thru in Brattleboro, and the state Agency of Agriculture has drafted rules governing the hemp and CBD business. Cary Giguere of the agency said the state will start limited testing of hemp and CBD products at a new lab in Randolph in mid-February.
Most Vermont banks and credit unions have been steering clear of lending to hemp or CBD-related businesses, although a few stepped into the market last year. That’s about to change.
“Given actions taken by Congress in the farm bill, banks are going to consider providing access to capital and financial services for hemp related businesses,” said Chris D’Elia, the president of the Vermont Bankers Association. “It may take a little bit to make sure all of the players, regulators and banks are on the same page, but it will happen.”
In August, Quist and Christianson hired a director of analytics and formulations, Keith Griswold, who is a partner in the firm and operates the facility’s laboratory. Like Christianson, Griswold had a scientific background, most recently serving as the lead analytical manager for a Pepsico R&D facility in Westchester, N.Y. Christianson has a PhD in chemistry, and Quist has a background in sales.
Quist said the plant extraction work underway at the Northeast Processing lab is not itself groundbreaking. It’s similar to the botanical extraction process used with any essential oil, such as lavender, orange blossom, or rose hip.
“We’ve certainly established protocols that are very unique, but we’re not reinventing the wheel here,” Quist said.
Griswold’s arrival at Northeast Processing changed the company’s direction. Where originally Christianson and Quist had planned to merely produce CBD oil and sell it, they said the company now works and consults with existing brands and provides ideas for new product development and analytical support for consumer products.
“Now that’s an expectation in our field,” Quist said.
Griswold said Northeast Processing gave him an opportunity to get into an emerging field, where industry standards are only now being developed.
“Having the opportunity to be part of that was a little too exciting for me to pass up,” he said. Under his leadership, Northeast Processing serves as a third-party tester for other CBD producers, creating reports on potency, THC levels, moisture content, and other measures.
Under FDA rules, CBD products cannot contain more than .3 THC, or tetrahydrocannabinol — the psychoactive ingredient found in small amounts in the hemp plant. In its proposed rules, Vermont puts that number at .39 percent per dry weight.
Quist, whose title is chief development officer, said it’s his job to talk to people about an industry that many still don’t understand.
“There’s a lot of conjecture in our industry,” he said. “There are people who have the most compelling stories about success with CBD and how it’s helped them, and I talk to people who are like, ‘Does it really do anything? Is it possible it’s a placebo?’”
Like many other Vermont and national CBD producers, the trio hope that the federal or state governments will soon start regulating and testing products to create verified product standards for the industry. Griswold said he serves on the cannabis subcommittee for ASTM International, the organization that produces standards for many industries.
“In June, the first industry standard for cannabis was published, so we’re getting there,” he said.
But there’s a long way to go, he added.
“From a testing perspective, there’s an enormous shortage of laboratories to support the boom in the cannabis industry right now,” Griswold said. “There are over 9,000 dispensaries nationally and something like 75 laboratories that were established to support these dispensaries – an incredible disparity.”
Hemp promoters have long lobbied for this day.
Just before Christmas, President Trump signed the bipartisan 2018 Congressional Farm Bill, which included a provision that effectively legalizes hemp in the U.S., as long as it contains no more than 0.3% of THC, the active ingredient in marijuana that gets people high, which industrial hemp does not.
The historic law, which takes effect this month, treats hemp as an agricultural commodity and removes it from the Drug Enforcement Agency’s list of schedule 1 drugs.
However, the Farm Bill empowers states to regulate (or ban) the production and sale of hemp within their borders, a move that would be counterproductive to local farmers who now have the option of growing a productive crop, while corn and soybean prices are low.
Promoters have long extolled the virtue of the grassy weed as one of the cheapest and most important crops for solving the world’s problems around sustainability and health—with it’s alleged ability to treat numerous symptoms and diseases. (And scientific studies support some of these claims.)
The plant, cannabis sativa, is one of the fastest growing crops and was one of the first plants to be spun into usable fiber 10,000 years ago. It is so diverse, it can be made into paper, rope, clothing, biodegradable plastics, paint, insulation, biofuel, food, and animal feed.
A hemp byproduct called cannabidiol, or “CBD oil”, still has some stringent rules so not just anyone can produce and sell the product. The non-intoxicating compound found in cannabis is now technically legal, if and only if the hemp is produced by a licensed grower in a manner consistent with the Farm Bill and associated federal and state regulations.
33 states have legalized cannabis for medical purposes. Over the past six years, 10 states have legalized cannabis and marijuana for adult use, however these are all technically banned under federal law—and the Farm Bill does nothing to change that.
With bipartisan support these laws are changing, and this is just another victory in a push toward common sense drug laws in America.
SHARE the Historic Farming News with Your Buddies… (Photo by kat_geb, CC license)
PotNetwork is pleased to bring you our Marijuana Stock Weekend from our partner publication Grizzle. Grizzle journalist and Head of Research Scott Willis covers the marijuana stock market in-depth, with over 12 years of institutional investment management experience in analyzing both debt and equity securities. He has held senior investment research roles at Credit Suisse and TD Asset Management. He’s also a Chartered Financial Analyst and has been featured on BNN Bloomberg and CBC. For more of Scott’s writing check out Grizzle – the language of new money.
Bottom Line: The scorecard is the most comprehensive resource on the internet for investors thinking of investing in U.S. marijuana growers. The scorecard is full of useful information like which stocks trade at a premium or a discount, who has the largest state footprint, do common shareholders have a say in how the business is run, and much more.
Bottom Line: “The first states to legalize marijuana, including Colorado, Washington, and California, did it through ballot initiatives. Now, governors and legislatures are making the decision. The politics of marijuana have changed, and lawmakers are increasingly framing legalization as a progressive, good-government policy.”
Bottom Line: This attorney general actually seems like an unlikely ally for the marijuana market. He explicitly stated he would not go after states who legalize the drug and supports a well thought out federal legalization strategy.
Bottom Line: Whistler currently is the most expensive brand on offer in BC’s online store ($18/gram), which may explain why Aurora was willing to pay such a high premium. Aurora needs to sell Whistler’s 5,000 kg of capacity for $17/gram for the next 10 years to generate a decent 10 percent return.
Bottom Line: A new CBD brand, Fleur Marche, started by former GOOP employees is charging $800-$1,500 per gram for CBD-infused beauty patches and creams. CBD oils from hemp cost only $0.08 to produce, giving you a feel for how profitably the CBD market is today.
Bottom Line: An ad for CBD oil played in Time’s Square on New Year’s Eve. The Farm Bill legalizing hemp has basically opened up the U.S. market to any type of CBD marketing. Expect to see products at your local gas station and ads for CBD products on buses, subways, and billboards very soon.
Bottom Line: Recent studies have shown older Americans use fewer prescription drugs in states that have legalized marijuana. The pharmaceutical industry is no doubt aware they are likely losing business to marijuana, which explains why they are circling growers looking for a way into the market.
Bottom Line: EastWest Biosciences is just one of many companies looking to get into the CBD space, however, this is a well done deep dive to help you understand how the CBD market may develop and the different verticals a company like EastWest is targeting.
Weekly marijuana stock performance
Marijuana stocks took a breather this week with the global index essentially flat. Large-Cap Canadian names outperformed U.S. operators by 6 percent, up 4 percent for the week. Mid-cap and small-cap Canadian stocks were up 1 percent and down 1 percent respectively. Stocks are still well off their October highs but have rebounded 35 percent off the lows reached in December.
Stocks are seeing a bounce back in the first quarter after selling off so heavily in November and December. Sentiment is getting more positive with the overall market so it is hard to see stocks going through another 20 percent-plus selloff in the first quarter without additional negative earnings news or a global recession. A full buyout of a cannabis company by a consumer packaged goods company would be a strong positive catalyst for the entire industry.
From a fundamental perspective, be careful owning cannabis stocks into the next two quarters of earnings. A supply shortage and a government monopoly do not bode well for licensed producers’ ability to meet or exceed earnings estimates.
Longer term, with the Canadian market legalized we expect retail and wholesale price compression from a legal oversupply by the second half of 2019. Falling cannabis prices will pressure producer stocks later in 2019. After a shakeout, the remaining stocks will be better positioned as long-term buying opportunities.
More From PotNetwork
Go To http://www.InsuredMeds.com for FREE Quotes & Info Go to https://www.SeniorJoints.com to order CBD and learn more about the many benefits …
For research referenced, go to — [link to blog post]
You’ll find these videos helpful too.
If you liked this video, please give it a thumbs up 👍 & share it with your friends.
Don’t forget to SUBSCRIBE —
CONNECT WITH DR. PATEL
DISCLAIMER: The information in this video and on the website ( is for educational and informational purposes only. It should not take the place of seeing a physician and should not be used to diagnose or treat a health problem or disease. It also does not establish a physician-patient relationship between you and Dr. Patel. Individual results may vary. The information contained in this video and on the website ( has not been evaluated by the FDA (Food and Drug Administration).
# CBD #CBDoil #CBDexpert #CBDdoctor
Please follow and like us:
Learn about the benefits of vaping and CBD products with Vape Huts in Wrexham, Vape Huts … CBD Oil: How To Make Cannabis Oil at Home – Easily!
How I Use CBD Products Every Day for Pain Relief. As/Is. Loading. …. What Happened To My Body | 60 Days of CBD Oil – Duration: 14:11. Megan …
Re: CBD oil from USA to Italy?
I don’t believe it is legal in Italy without a doctor’s prescription…I might be wrong. I just checked a bunch of Italian web pages to get some info on it. It is available in pharmacies, but everybody says you must have prescription.
Also I would check with TSA web page. I don’t believe you can fly with that, you risk confiscation.
Maybe if you bring the capsules they might just consider them part of you personal medications…but I am not telling you to do something potentially illegal…
nobody at the airports has ever questioned me about my pills.